|
| Press Releases |
|
 |
|
| Wednesday, June 22, 2022 |
|
|
エーザイ、「レカネマブ」の潜在的な経済価値について査読学術専門誌Neurology and Therapy誌に掲載 |
| エーザイ株式会社（本社：東京都、代表執行役 CEO：内藤晴夫）は、このたび、早期アルツハイマー病（AD）当事者様に対する抗アミロイドβ（Aβ）プロトフィブリル抗体レカネマブ（開発品コード：BAN2401）の潜在的な経済価値について、米国における医療費支払者観点および社会的観点から、検証済の疾患シミュレーション・モデル（AD Archimedes Condition Event simulation：AD ACE モデル 1,2,3）を用いて推定した初期段階の評価結果が査読学術専門誌Neurology and Therapy 誌に掲載されたことをお知らせします。 more info >> |
|
| Friday, June 17, 2022 |
|
|
エーザイ、人事異動ならびに組織改編（2022年6月17日付）を発表 |
| エーザイ株式会社は本日、人事異動ならびに組織改編（2022年6月17日付）を以下のとおり発表しました。 more info >> |
|
| Thursday, June 9, 2022 |
|
|
エーザイ、2023年3月期業績予想（IFRS）の修正に関するお知らせ |
| 直近の業績の動向等を踏まえ、2022年5月13日に公表した2023年3月期（2022年4月1日から2023年3月31日）の業績予想を下記のとおり修正しますのでお知らせします。 more info >> |
|
| Monday, June 6, 2022 |
|
|
Eisai Presents New Findings for Antibody Drug Conjugate Farletuzumab Ecteribulin at 2022 ASCO Annual Meeting |
| Eisai Co., Ltd. announced today new investigational data from the platinum-resistant ovarian cancer (PROC) cohort expansion of a Phase 1 study (Study 101) evaluating the antibody drug conjugate (ADC) co-developed by Eisai and Bristol Myers Squibb, farletuzumab ecteribulin (MORAb-202). more info >> |
|
|
エーザイ、米国臨床腫瘍学会年次総会において抗体薬物複合体farletuzumab ecteribulinの最新の知見を発表 |
| エーザイ、米国臨床腫瘍学会年次総会において抗体薬物複合体farletuzumab ecteribulinの最新の知見を発表 more info >> |
|
| Friday, June 3, 2022 |
|
|
Eisai to Present Latest Data on Lemborexant at The 36th Annual Sleep 2022 Meeting |
| Eisai Co., Ltd. announced a total of seven poster presentations including the latest data on its in-house discovered orexin receptor antagonist lemborexant (product name: DAYVIGO) will be given at the 36th annual meeting of the Associated Professional Sleep Societies (SLEEP 2022), to be held from June 4 to 8, 2022, in Charlotte, NC, the United States. more info >> |
|
| Friday, May 27, 2022 |
|
|
Eisai Contributes to the Science of Cancer Medicine at ASCO 2022 |
| Eisai Co., Ltd. announced today the presentation of research across various types of cancer from its oncology portfolio during the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting (#ASCO22), which is taking place virtually and in-person in Chicago from June 3 to 7. more info >> |
|
|
Eisai: MHLW Grants Orphan Drug Designation in Japan to Mecobalamin Ultrahigh-Dose Formulation with Prospective Indication for Delaying the Progression of Disease and Functional Impairment of ALS |
| Eisai Co., Ltd. announced today that it has received orphan drug designation for ultrahigh-dose mecobalamin, with a prospective indication for delaying the progression of disease and functional impairment of amyotrophic lateral sclerosis (ALS), by the Ministry of Health, Labour and Welfare (MHLW). more info >> |
|
|
エーザイ、米国臨床腫瘍学会年次総会おけるがん領域の開発品・製品に関する発表について |
| more info >> |
|
|
エーザイ、メコバラミンの高用量製剤がALSの病態及び機能障害の進行抑制を予定される効能又は効果として、厚生労働省より希少疾病用医薬品に指定 |
| エーザイ株式会社（本社：東京都、代表執行役 CEO：内藤晴夫）は、このたび、メコバラミンの高用量製剤について、筋萎縮性側索硬化症（Amyotrophic Lateral Sclerosis: ALS）の病態及び機能障害の進行抑制を予定される効能又は効果として、厚生労働省より希少疾病用医薬品に指定されたことをお知らせします。 more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
Geo Energy's Integrated Infrastructure Project Achieves 80% Completion; Secures Two Binding Term Sheets with Third Parties for 9 Million Tonnes Annual Haulage; Coal Prices Surge Amid Global Tensions
Mar 18, 2026 03:41: JST
|
|
|
Maxon、リアルタイム建築ビジュアライゼーションソリューションでAEC市場に正式参入
Mar 17, 2026 23:05: JST
|
|
|
Maxon, 실시간 Archviz 솔루션으로 AEC 시장 공식 진출
Mar 17, 2026 22:05 HKT/SGT
|
|
|
Maxon推出即時Archviz解決方案，正式進軍AEC市場
Mar 17, 2026 22:05 HKT/SGT
|
|
|
Maxon推出实时Archviz解决方案，正式进军AEC市场
Mar 17, 2026 22:05 HKT/SGT
|
|
|
Maxon Marks Its Official Entry Into the AEC Market With Its Real-Time Archviz Solution
Mar 17, 2026 22:05 HKT/SGT
|
|
|
FinHarbor Introduces Rapid-Deployment Neobank Platform for 30-Day Go-Live
Mar 17, 2026 22:00: JST
|
|
|
FinHarbor Introduces Rapid-Deployment Neobank Platform for 30-Day Go-Live
Mar 17, 2026 22:00 HKT/SGT
|
|
|
Geo Energy's Integrated Infrastructure Project Achieves 80% Completion; Secures Two Binding Term Sheets with Third Parties for 9 Million Tonnes Annual Haulage; Coal Prices Surge Amid Global Tensions
Mar 17, 2026 23:00 JST
|
|
|
FILMART and EntertainmentPulse open today
Mar 17, 2026 21:41: JST
|
|
|
FILMART and EntertainmentPulse open today
Mar 17, 2026 21:41 JST
|
|
|
鍋圈(2517.HK)核心經營利潤勁增 四店齊發驅動長期成長
Mar 17, 2026 20:30 HKT/SGT
|
|
|
锅圈(2517.HK)核心经营利润劲增 四店齐发驱动长期成长
Mar 17, 2026 20:24 HKT/SGT
|
|
|
GUOQUAN FOOD (2517.HK) Surging core operating profit, Four Stores Jointly Advancing with Concerted Efforts for Long-Term Growth
Mar 17, 2026 20:15 HKT/SGT
|
|
|
TANAKA PRECIOUS METAL GROUP Provides Medals, Commemorative Items, and Trophies as Category Sponsor (Awards Ceremonies) for the LIGA.i Blind Soccer Top League 2025
Mar 17, 2026 21:00 JST
|
|
|
|
|
More News >> |
|
|
|
|
|
